Rituximab Prevents Stroke Recurrences in Atypical Chronic Immune-Mediated Thrombotic Thrombocytopenic Purpura
Main Authors: | Henry Dupuy, Estibaliz Lazaro, Irène Machelart, Jean-François Viallard, Paul Coppo, Etienne Rivière |
---|---|
Format: | Article |
Language: | English |
Published: |
Georg Thieme Verlag KG
2018-10-01
|
Series: | TH Open |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1676357 |
Similar Items
-
Atypical Thrombotic Thrombocytopenic Purpura Presenting as Stroke
by: Pradeepthi Badugu, et al.
Published: (2019-01-01) -
Clopidogrel-induced refractory thrombotic thrombocytopenic purpura successfully treated with rituximab
by: Sara Khodor, et al.
Published: (2016-06-01) -
Thrombotic Thrombocytopenic Purpura
by: Nuchanat Nonsee, et al.
Published: (2015-02-01) -
Atypical Presentation of Thrombotic Thrombocytopenic Purpura without Hematological Features
by: Balraj Singh, et al.
Published: (2020-07-01) -
Thrombotic Thrombocytopenic Purpura and Gemcitabine
by: Pashtoon Murtaza Kasi
Published: (2011-03-01)